It has been suggested that NPM1 loss of function could lead to an acceleration of tumorigenesis owing to the destabilization and inactivation of ARF, which is known to inhibit cell proliferation through both p53-dependent and p53-independent mechanisms [3,29], in agreement with a potential tumor-suppressor role for NPM1. The gene discussed is TP53; the disease is neoplasm.